Fractyl Health Common Stock Net 2023-2025 | GUTS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Fractyl Health common stock net from 2023 to 2025. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Fractyl Health common stock net from 2023 to 2025. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$72B
Zoetis (ZTS)	$69.3B
Takeda Pharmaceutical (TAK)	$47.7B
Daiichi Sankyo, - (DSNKY)	$45.3B
BeOne Medicines - (ONC)	$33.5B
Sandoz Group AG (SDZNY)	$27.7B
Summit Therapeutics (SMMT)	$17.6B
Merck (MKKGY)	$16.4B
Shionogi (SGIOY)	$14.6B
Neurocrine Biosciences (NBIX)	$13.8B
United Therapeutics (UTHR)	$13.7B
IPSEN (IPSEY)	$11.4B
Orion OYJ (ORINY)	$11.2B
Madrigal Pharmaceuticals (MDGL)	$9.7B
Eisai (ESAIY)	$8.9B
Corcept Therapeutics (CORT)	$7.3B
Stevanato Group S.p.A (STVN)	$7B
Grifols, S.A (GRFS)	$6.9B
Ionis Pharmaceuticals (IONS)	$6.8B
Ono Pharmaceutical (OPHLF)	$5.7B
Hikma Pharmaceuticals Plc (HKMPF)	$5.4B
Soleno Therapeutics (SLNO)	$3.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$3B
Crinetics Pharmaceuticals (CRNX)	$2.9B
NewAmsterdam Pharma (NAMS)	$2.7B
Hypermarcas (HYPMY)	$2.7B
Procaps Group, S.A (PROCF)	$2.6B
Catalyst Pharmaceuticals (CPRX)	$2.5B
Centessa Pharmaceuticals (CNTA)	$2.2B
Ocular Therapeutix (OCUL)	$2.1B